Surova Yulia, Nilsson Markus, Lampinen Björn, Lätt Jimmy, Hall Sara, Widner Håkan, van Westen Danielle, Hansson Oskar
Department of Clinical Sciences, Lund, Lund University, Lund, Sweden.
Department of Neurology Lund, Skåne University Hospital, 221 85, Lund, Sweden.
Neuroradiology. 2018 Mar;60(3):247-254. doi: 10.1007/s00234-017-1971-3. Epub 2018 Jan 24.
In Parkinson's disease (PD), pathological microstructural changes occur that may be detected using diffusion magnetic resonance imaging (dMRI). However, there are few longitudinal studies that explore the effect of disease progression on diffusion indices.
We prospectively included 76 patients with PD and 38 healthy controls (HC), all of whom underwent diffusion kurtosis imaging (DKI) as part of the prospective Swedish BioFINDER study at baseline and 2 years later. Annualized rates of change in DKI parameters, including fractional anisotropy (FA), mean diffusivity (MD), and mean kurtosis (MK), were estimated in the gray matter (GM) by placing regions of interest (ROIs) in the basal ganglia and the thalamus, and in the white matter (WM) by tract-based spatial statistics (TBSS) analysis.
When adjusting for potential confounding factors (age, gender, baseline-follow-up interval, and software upgrade of MRI scanner), only a decrease in FA in the putamen of PD patients (β = - 0.248, P < .01) over 2 years was significantly different from the changes observed in HC over the same time period. This 2-year decrease in FA in the putamen in PD correlated with higher L-dopa equivalent dose at baseline (Spearman's rho = .399, P < .0001).
The study indicates that in PD microstructural changes in the putamen occur selectively over a 2-year period and can be detected with DKI.
在帕金森病(PD)中,会出现可通过扩散磁共振成像(dMRI)检测到的病理性微观结构变化。然而,很少有纵向研究探讨疾病进展对扩散指数的影响。
我们前瞻性纳入了76例PD患者和38名健康对照者(HC),他们均在基线期和2年后作为瑞典前瞻性生物标志物研究的一部分接受了扩散峰度成像(DKI)。通过在基底神经节和丘脑放置感兴趣区域(ROI)来估计灰质(GM)中DKI参数(包括分数各向异性(FA)、平均扩散率(MD)和平均峰度(MK))的年化变化率,并通过基于纤维束的空间统计(TBSS)分析来估计白质(WM)中的年化变化率。
在调整潜在混杂因素(年龄、性别、基线至随访间隔以及MRI扫描仪的软件升级)后,仅PD患者壳核中FA在2年内的下降(β = -0.248,P <.01)与同期HC中观察到的变化有显著差异。PD患者壳核中FA的这种2年下降与基线时较高的左旋多巴等效剂量相关(Spearman相关系数ρ =.399,P <.0001)。
该研究表明,在PD中,壳核的微观结构变化在2年期间选择性发生,并且可以通过DKI检测到。